...
首页> 外文期刊>The Journal of Nutritional Biochemistry >TRAF6 is functional in inhibition of TLR4-mediated NF-kappa B activation by resveratrol
【24h】

TRAF6 is functional in inhibition of TLR4-mediated NF-kappa B activation by resveratrol

机译:TRAF6在白藜芦醇抑制TLR4介导的NF-κB活化中起作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Resveratrol was suggested to inhibit Toll-like receptor (TLR)4-mediated activation of nuclear factor-kappa B (NF-kappa B) and Toll/interleukin-1 receptor domain-containing adaptor inducing interferon-beta (TRIF)-(TANK)-binding kinase 1, but the myeloid differentiation primary response gene 88 tumor necrosis factor receptor-associated factor 6 (TRAF6) pathway is not involved in this effect. However, involvement of TRAF6 in this process is still elusive since cross talk between TRIP and TRAF6 has been reported in lipopolysaccharide (LPS)-induced signaling. Using RAW 264.7 macrophages, we determined the effect of resveratrol on LPS-induced TRAF6 expression, ubiquitination as well as activation of mitogen-activated protein (MAP) kinases and Akt in order to elucidate its involvement in TLR4 signaling. LPS-induced transient elevation in TRAF6 mRNA and protein expressions is suppressed by resveratrol. LPS induces the ubiquitination of TRAF6, which has been reported to be essential for Akt activation and for transforming growth factor-p activated kinase-1 NAP kinase kinase 6 (MKK6)-mediated p38 and c-Jun N-terminal kinase (JNK) activation. We found that resveratrol diminishes the effect of LPS on TRAF6 ubiquitination and activation of JNK and p38 MAP kinases, while it has no effect on the activation of extracellular-signal-regulated kinase (ERK)1/2. The effect of resveratrol on MAP kinase inhibition is significant since TRAF6 activation was reported to induce activation of JNK and p38 MAP kinase while not affecting ERK1/2. Moreover, Akt was identified previously as a direct target of TRAF6, and we found that, similarly to MAPKs, phosphorylation pattern of Akt followed the activation of TRAF6, and it was inhibited by resveratrol at all time points. Here, we provide the first evidence that resveratrol, by suppressing LPS-induced TRAF6 expression and ubiquitination, attenuates the LPS-induced TLR4 TRAF6, MAP kinase and Akt pathways that can be significant in its anti-inflammatory effects
机译:白藜芦醇被认为可以抑制Toll样受体(TLR)4介导的核因子-κB(NF-κB)和含Toll / interleukin-1受体域的衔接子诱导干扰素-β(TRIF)-(TANK)的活化。结合激酶1,但髓样分化主要反应基因88肿瘤坏死因子受体相关因子6(TRAF6)通路不参与此作用。但是,TRAF6在该过程中的参与仍然难以捉摸,因为据报道在脂多糖(LPS)诱导的信号传导中TRIP和TRAF6之间存在串扰。我们使用RAW 264.7巨噬细胞,确定白藜芦醇对LPS诱导的TRAF6表达,泛素化以及丝裂原激活蛋白(MAP)激酶和Akt激活的作用,以阐明其参与TLR4信号传导的作用。白藜芦醇可抑制LPS诱导的TRAF6 mRNA和蛋白质表达的瞬时升高。 LPS诱导了TRAF6的泛素化,据报道这对于Akt激活以及转化生长因子-p激活的激酶-1 NAP激酶6(MKK6)介导的p38和c-Jun N-末端激酶(JNK)激活至关重要。我们发现白藜芦醇减少了LPS对TRAF6泛素化和JNK和p38 MAP激酶激活的影响,而对细胞外信号调节激酶(ERK)1/2的激活没有影响。白藜芦醇对MAP激酶的抑制作用是显着的,因为据报道TRAF6激活可诱导JNK和p38 MAP激酶的激活,而不影响ERK1 / 2。此外,以前已将Akt鉴定为TRAF6的直接靶标,我们发现,与MAPKs相似,Akt的磷酸化模式也跟随TRAF6的活化,并且在所有时间点均被白藜芦醇抑制。在这里,我们提供了第一个证据,即白藜芦醇通过抑制LPS诱导的TRAF6表达和泛素化,减弱了LPS诱导的TLR4 TRAF6,MAP激酶和Akt通路,这在其抗炎作用方面可能是重要的

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号